chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Very painful shoulder 24 hours later; pounding heart rate felt in my chest that lasted less than 30 sec; with in 5 minutes of inoculation experienced an odd taste in my mouth; Warm sensation in Left upper arm for at least 15 minutes.; This is a spontaneous report from a contactable other Health Care Professional (HCP). A 53-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) via an unspecified route of administration on 23Dec2020 at 13:15 (at the age of 53-years-old) at an unspecified dose in the left arm for COVID-19 vaccination. Medical history included pneumonia, high cholesterol, eczema rashes from perfumes/beauty products/soaps and hand dermatitis all on unknown dates.The patient is allergic to amoxicillin (rash trunk) and experiences seasonal allergies in the eyes/nose/with coughing. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient was not pregnant at the time of vaccination. The patient was administered the vaccine in the hospital. There were no concomitant medications. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 23Dec2020 at 13:20 (reported as "within 5 minutes of inoculation") the patient experienced an odd taste in her mouth, a pounding heart rate felt in her chest that lasted less than 30 seconds (may have been shorter). She stated that she was trying to stay calm. Also, she experienced a warm sensation in the left upper arm for at least 15 minutes as well as a very painful shoulder twenty-four hours later; there was no swelling nor redness noted. Her shoulder was much improved by the third day.The patient did not receive any treatment for the events. The clinical outcomes of heart rate increased, taste peculiar, localized feeling of warmth and shoulder pain were reported as recovered on an unspecified date in Dec2020. It was also reported that since the vaccination the patient had not been tested for COVID-19.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
After receiving H1N1 Flumist, student c/o coughing, throat tightness, dizziness & sore throat. LCTA. BENADRYL 25mg po given. Student reported sx improvement. Dad notified who picked up student & took home with understanding to take to ER or MD if sx worsen.
Smallpox vaccine administered-pt developed a satellite lesion approximately 6cm away from primary inoculation site, and rash on torso-flat/red/com site round, non-blanching
Arm weakness ache that started right away after receiving flu vaccine. Lasted for a few months and then affected right arm. Had PE and protein in urine a few months later. I believe this set off a response due to flu vaccine.
One hour after administration injection site pain that radiated into armpit, 7/10, burning and sharp,lasted one hour. Then burning,pressure started to radiate across her chest to sternum and base of neck, uncomfortable sensation, lasted into next day. No shortness of breath or wheezing. No nausea or vomiting. No numbness or tingling. No itching or skin rash. Next day still symptomatic seen in urgent care. IV fluids and Toradol IV given,symptoms resolved in 3 hours.
Every time patient got a flu shot, he came down with the flu; Initial information was received on 12-Oct-2020 regarding an unsolicited valid non-serious social media case from a consumer via social media.  This case involves a male patient age not reported who experienced the flu (influenza), while he received INFLUENZA VACCINE.  Medical history, past medical treatments, vaccinations, concomitant medication and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE (Produced by unknown manufacturer, lot number and expiration date not reported) via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient who developed non-serious flu (influenza), (unknown latency) following the administration of INFLUENZA VACCINE.  Laboratory data was not reported.   It was not reported if the patient received any corrective treatment or not.  The outcome of the event was unknown at the time of reporting.  There will be no information on the lot number for this case.
Loose mucusy stool go to ROTATEQ vaccine 10/29/08 no fever no Rx.
About 4 hours after vaccine administration patient reported fever chills muscle aches nausea fatigue lasted for 48 hours.
CHOLESTEROL LEVEL UP; Low grade fever; This spontaneous case was reported by a consumer and describes the occurrence of BLOOD CHOLESTEROL INCREASED (CHOLESTEROL LEVEL UP) and PYREXIA (Low grade fever) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product UPADACITINIB (RINVOQ) for Rheumatoid arthritis.    No Medical History information was reported.   In April 2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In April 2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In September 2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient started UPADACITINIB (RINVOQ) (Oral) at an unspecified dose. In 2021, the patient experienced PYREXIA (Low grade fever). On an unknown date, the patient experienced BLOOD CHOLESTEROL INCREASED (CHOLESTEROL LEVEL UP). At the time of the report, BLOOD CHOLESTEROL INCREASED (CHOLESTEROL LEVEL UP) was resolving and PYREXIA (Low grade fever) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood cholesterol: Cholesterol level up.         No relevant concomitant medications were reported.   The reporters causality for the event of cholesterol level up with rinvoq (upadacitinib) was no reasonable possibility. The reporters causality for the events of low grade fever was not provided.  It was unknown if patient was enrolled in a COVID-19 Vaccine Trial.  No treatment information was provided.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna
Whole arm is hurting up to the breast/arm is sore; Has a mild swelling; Achy symptoms/is in pain; Really bad headache; Lymph nodes are swollen next to the armpit; Chills; A spontaneous report, was received from a physician (patient), concerning herself, a 67 years-old female patient, unknown race and ethnicity, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced whole arm is hurting up to the breast/arm is sore (pain in extremity), has a mild swelling (peripheral swelling), achy symptoms/is in pain (pain), really bad headache (headache), lymph nodes are swollen next to the armpit (lymphadenopathy), and chills.  The patient's medical history was not provided. The patient's historical vaccine included flu shot which was two months ago on an unknown date in Nov 2020. No concomitant medications were reported.  On 05 Jan 2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (Lot number: Unknown) intramuscularly in left arm for prophylaxis of COVID-19 infection.   On 06 Jan 2021, the patient experienced that the whole arm was hurting up to the breast, lymph nodes are swollen next to the armpit, mild swelling, is in pain, really bad headache (the patient took caffeine for it), achy symptoms and chills. The patient stated that is usually pain in the injection site when gets a vaccine but not like this, including the whole arm. The patient has headache, which was difficult to deal with, chills too (on going), and the arm was sored still, the whole arm. No treatment was administered for the events.   Action taken with second dose of mRNA-1273 in response to the events was not provided.  The outcome for the events, whole arm is hurting up to the breast/arm is sore and chills were considered as not recovered, and that of events has a mild swelling, achy symptoms/is in pain, really bad headache and lymph nodes are swollen next to the armpit were unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Swollen arm (not just at site of injection), elevated large bump at site of injection, 3x3? rash five inches away from injection site on inside of arm   Lasting one week in duration
Frequent nose bleeds. 1x/week since 2nd vaccine. This is out of the usual for patient. First one happened the evening after dose #2.
c/o fever, chills, body aches, and lightheadedness after recieving J&J COVID vaccine yesterday.  Pt states tylenol and motrin have been effective.  Pt denies N/V/D; ambulates with steady gait without assistance.
Narrative: Pt is a 74 y/o male who was administered the first dose of Pfizer COVID-19 vaccination on 2/17. s/p pancreatic biopsy on 2/26, per pt's daughter, pt was rapidly declining with generalized weakness and overall functional decline and admitted to ER on 3/2. pt also had multiple falls since discharge from hospital on 2/27. Before expiring 3/18/21, pt has been admitted to the ICU after being found to be septic 2/2 bacteremia and having hepatic abcess.
Patient was vaccinated 82307 with vaccinia, also had anthrax vaccine on 818 and 830, as well as typhoid on 81807. On 9/2/07 c/o headache, 9/3/07 and nausea and "feeling going crazy", admitted to WM on 9/4/07 with progressive encephalopathy. LP with lymphocytic pleocytosis, neg gs, no growth 48 hrs. Intubated (for aw prot) tx to MICU. MRI at hospital shows diffuse white>gray matter changes c/w ADEM.   10/19/07 Reviewed hospital medical records which reveal patient experienced 2-3 days of AMS, fever & confusion.  Admitted 9/5-10/01/2007.  Transferred from outlying ER.  Intubated.  Neurology consult done.  Tx w/IV steroids, IV antibiotics, IV antivirals & IVIG x 4 days.  Also tx w/vaccinia immunoglobulin x 1 dose after consult w/CDC.   Improved but remained universally weak, esp in legs bilaterally & required assistance to function. Required I/O catheterizations q8h on transfer.  Also had rash thought to be secondary to steroids.  Transferred to inpatient rehab unit 10/1-10/9/07. Continued to need supervision w/ADLs on d/c.  Had left vocal cord paralysis & UTI at time of d/c.  FINAL DX: acute demyelinating encephalomyelitis (ADEM) secondary to vaccinia.
Received hib and PREVNAR immunization (1st dose of each). Prolonged crying and skin reaction at site of PREVNAR. Treatment advised was acetaminophen/cool - cold pack and observation. No adverse reaction on the next day.
Intussusception, ileocolic and then on 12/26 small bowel intussusception.
About 12 hours after the injection- fever, chills, aches, fatigue for about 48 hours.
shaking; chills; nausea; This spontaneous case was reported by a consumer and describes the occurrence of TREMOR (shaking), CHILLS (chills) and NAUSEA (nausea) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced TREMOR (shaking), CHILLS (chills) and NAUSEA (nausea). At the time of the report, TREMOR (shaking), CHILLS (chills) and NAUSEA (nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported.
4-month patient received Kinrix; This case was reported by a physician via call center representative and described the occurrence of inappropriate age at vaccine administration in a 4-month-old male patient who received DTPa-IPV (Kinrix) for prophylaxis.   Co-suspect products included dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 23rd October 2021, the patient received Kinrix and Kinrix Pre-Filled Syringe Device. On 23rd October 2021, unknown after receiving Kinrix and Kinrix Pre-Filled Syringe Device, the patient experienced inappropriate age at vaccine administration. On an unknown date, the outcome of the inappropriate age at vaccine administration was unknown.     This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: The physician reported that a 4-month old male patient was administered Kinrix inadvertently, which led to inappropriate age at vaccine administration. The reporter consented to follow up.
outside of 42 day mark; Should have had her second vaccine on 31 Mar 2021; missed her appointment; This spontaneous case was reported by a pharmacist (subsequently medically confirmed) and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (outside of 42 day mark), PRODUCT DOSE OMISSION ISSUE (Should have had her second vaccine on 31 Mar 2021) and PRODUCT DOSE OMISSION ISSUE (missed her appointment) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Mar-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (missed her appointment). On 22-Apr-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (outside of 42 day mark) and PRODUCT DOSE OMISSION ISSUE (Should have had her second vaccine on 31 Mar 2021). At the time of the report, PRODUCT DOSE OMISSION ISSUE (outside of 42 day mark), PRODUCT DOSE OMISSION ISSUE (Should have had her second vaccine on 31 Mar 2021) and PRODUCT DOSE OMISSION ISSUE (missed her appointment) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Information has been received from a consumer concerning his 77 year old wife with depression, Penicillin allergy, Sulfonamide allergy, LEVAQUIN allergy and AVELOX allergy and a history of thyroid removal due to cancer who on 11-Nov-2008 was vaccinated with a dose of ZOSTAVAX "injection". Concomitant therapy included BENICAR, ZOLOFT, SYNTHROID, Aspirin, ACTONEL, LIPITOR, LUNESTA, NEXIUM, RESTASIS and an unspecified pain medication. On approximately 14-Nov-2008, "3 to 4" days after vaccination", the patient experienced red rash on her arms and chest after receiving ZOSTAVAX. The patient was treated with prednisone and the rash resolved but returned after she discontinued therapy with Prednisone. The consumer reported that the physician felt that the rash may be related to lupus but they are unsure at this point. On an unspecified date, "unspecified blood tests" were performed (results not provided). The patient was not recovered. The patient sought physician and dermatologist medical attention. Upon internal review, possible lupus was considered to be an other important event. Additional information has been requested.
patient developed a red rash about 2 inches in size on the arm she got the vaccination in. but it was not right at the injection site, it was underneath where she had received the vaccine. she said it was not itchy, painful, or irritated, just red. believe it to be "COVID arm", but told her to keep an eye on it and if it gets worse, seek medical care
Information regarding PREVNAR was received from a consumer regarding a 12-month-old male patient who experienced "low grade fever, 100-100.4", very irritable and crying.  The patient received a dose on 02-Jul-2007.  Relevant medical history was not provided.  Product was administered on 02-Jul-2007.  Additional suspect medication included Varicella Virus Vaccine, Live.  Concomitant medications were not reported.  The patient's grandmother states that her grandson has been very irritable and crying since 02-Jul-2007.  She denies local site reaction and states that the patient has been running a "low grade fever, 100-100.4".  The outcome of the events is unknown.  No additional information was available at the time of this report.
Patient was given Pfizer Covid -19 vaccine at 10:13am. Five minutes after administration patient reported "not feeling well", did not vomit but complained of nausea. There was a potential syncope event for ~2 seconds where the head drooped. Paramedics were called upon patient request and patient was transported to local hospital.
Got really sick, and tired and was in bed for 3 days....escalated to Sinus infection, I lost my sense of smell which was really weird becasue I have had sinus infections my whole life and never had any entire loss of smell, I tested for covid before and after 4 days in a row and no covid....my smell finally came back but was experiencing nerve issues in right foot.... my right foot feeling heavy and numbness, also I have been having muscle weakness in legs and looks like they have atrophied a little (not sure if this is because I stopped running due to injury in hamstring)...... also bruising a lot and have had bleeding in between periods.  After the sinus infection I also got a bladder infection followed by a yeast infection.  It was like the vaccine completely wiped me out my head and body have felt weird since.  Now to date I still have a little numbness in my right foot, my smell is back, I have had a few tension headaches that wrap around my entire head (treated with massage and chiropractor) which I have never had before.   My first covid shot I also got really sick and my 4th one I had issues too with lymph nodes in armpit swelling and tons of muscle pains and aches.  Have not gone to all my doctors yet, I am going to schedule one with main physician soon.... this week going to OBGYN for ultrasounds and blood work first from the weird bleeding and infections following vaccine.
1 week post-smallpox vaccination patient presented with left, lower eyelid pustules, diagnosed as vaccinia blepharitis by ophthalmologist. Review of smallpox questionnaire shows patient responded he did have a skin problem (yes to question #9).  The questionnaire was not reviewed by a physician or completed by vaccine administrator. Follow-up: Per MD/Reporter there was no contraindication to Smallpox vaccination. I'm very glad that you contacted me since about 10 minutes after submitting the report I found that the patient actually had 2 smallpox questionnaires. The one that I initially saw was actually from his home station from Dec 2005 and the back page was not completed and he did not receive the vaccine at that time. The questionnaire for the date of his vaccination was found and it was completed correctly and he did not have any contraindication to the smallpox vaccinatin and provider approval was given - much to every's relief for the 10 minutes when we thought it had been administered to someone with a potential contraindication!  Thanks for the VAERS report #252297 ref: possible reaction to smallpox vaccination! And just need the name of the hospital where pt was admitted so that I can obtain records for the 1 day hospitalization to go along with your report. If you have the phone number for the hospital, that would be awesome. However, just the name would be a good start.
Chills Dizzy Body aches Excruciating headache Feverish  For almost 2 days Nausea
sz lasting 10-15min;no fever;generalized shaking w/stiffening;on apnea monitor @ the time-no alarms;
Report 20010014811 describes shortness of breath in an "adult" vaccinee of unspecified age and gender. Allergies, medical history, and concomitant medications are not specified. On an unspecified date, following the unspecified dose of engerix-B, the vaccinee experienced flusing, ecchymosis and shortness of breath. As of 01/19/2001, the outcome of the events is unknown.
The night of the vaccination I woke up in the middle of the night with a severe cramp in my calf muscle. The following day I still had more cramps in my right leg and foot for 48 hours. I also felt very fatigued. I went to see my doctor six days after vaccination, and she did blood work which came back normal. I am still feeling fatigue after two weeks it is a constant feeling of tiredness.
Information has been received from a RN concerning a 7 yr old male who on 13Dec00 was vaccinated with a dose of varicella virus vaccine live (lot636566/0923K). On 29Jan06 the pt developed chickenpox characterized by itchy, crusting, pimple like blisters. Unspecified medical attention was sought. It was reported that the symptoms lasted 3 days and the pt subsequently recovered. No product quality complaint was involved. Additional information has been requested.
Left deltoid swollen & red, patient also had left eye swollen & hives on lower abd. Gave PATANOL for eyes.
This spontaneous report as received from a pharmacist refers to a 4 months old patient. On 04-SEP-2012 the patient received a dose of ROTATEQ (lot # 669085/1659Z) orally that expired on 29-AUG-2012. No adverse effects had been demonstrated or reported. It was unspecified whether the patient sought for medical attention. The outcome was unknown. Additional information has been requested.
Large amount of muscle pain and headache, uncontrollable shivering though husband says it felt like my temperature was high (fever).
7 1/2 hrs p/vax had a pale episode lasting 10mins;not hyporesponsive or hypotonic; exam 30-45mins p/episode admitted for observation;EKG nl;admitted 15NOV; home 16NOV
This spontaneous report as received from a physician refers to a 65 year old female patient. In 2009 the patient was vaccinated with ZOSTAVAX, (route and dose unknown). On 11-JUL-2014 the patient was diagnosed with shingles after receiving ZOSTAVAX. The outcome of shingles was reported as recovered/resolved on an unknown date. The patient was treated with unspecified treatment. The patient sought medical attention by an office visit on an unspecified date. Additional information has been requested.
Right thigh swelling and redness, growing to attain a maximum 7" across in width and 4.5" in length.